Management to Showcase Full Nature-Cide Product Line at Industry's Flagship Event LOS ANGELES, CA / ACCESS Newswire / October ...
Light Chain Bioscience, a clinical-stage biotechnology company advancing the next generation of bispecific antibodies to treat cancer, today presented positive results from a Phase 1/1b study of ...
Edition" report has been added to ResearchAndMarkets.com's offering.The global healthcare CMO market was valued at US$145.83 billion in 2023, and is predicted to grow to US$291.25 billion in 2029. The ...
Oscar Health, Inc. (NYSE: OSCR), a leading healthcare technology company, is introducing a suite of easy-to-use health plans and AI features for millions of people for 2026 open enrollment.“Choice is ...
SHELTON, CT / ACCESS Newswire / October 20, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV-387 has shown strong ...
RATIONALE-307 and -312 – reinforce the PD-1 inhibitor’s proven clinical benefit in both NSCLC and ES-SCLCEarly data from investigational HPK1 inhibitor BGB-26808, in combination with TEVIMBRA, show ...
NAPLES, FL / ACCESS Newswire / October 20, 2025 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, announces core products are available for shipment after overcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback